Looking Into 23andMe Holding’s Recent Short Interest
23andMe Holding’s (NYSE:ME) short percent of float has fallen 6.06% since its last report. The company recently reported…
23andMe Therapeutics Present Preliminary Phase 2 Safety And Efficacy Results For 23ME-00610, Targeting CD200R1, At The 2024 ASCO Annual Meeting
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and tolerability, and
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers OneMedNet (NASDAQ:ONMD) stock moved upwards by 15.6% to $1.7 during Thursday’s after-market session. The company’s market cap…
23andMe To Present Preliminary Efficacy And Biomarker Data For 23ME-00610 At The 2024 ASCO Annual Meeting
23andMe Holding Co. (NASDAQ:ME) ("23andMe"), a leading human genetics and biopharmaceutical company, today announced that two abstracts on 23ME-00610, a first-in-class anti-CD200R1 antibody, have been accepted for poster
Nasdaq Down 0.5%; Lithium Americas Shares Slide
U.S. stocks traded mostly lower toward the end of trading, with the NASDAQ Composite falling around 0.5% on…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday’s regular session. The market value…
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow…
Once Valued At Billions, 23andMe’s CEO Considers Privatization To Secure Company’s Future
Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential breakthroughs.
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday’s session despite better-than-expected first-quarter results. The company…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday’s pre-market session. The market value of…